Patents by Inventor Russell Morris

Russell Morris has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230346990
    Abstract: Disclosed herein are compositions comprising high molecular weight heparin. The compositions comprise an effective amount of high molecular weight heparin having an average molecular weight from about 20 kDa to about 40 kDa and having a purity of at least 50%, and a pharmaceutically acceptable excipient. Disclosed herein are also methods of treating eosinophil-related inflammation in a subject.
    Type: Application
    Filed: February 10, 2021
    Publication date: November 2, 2023
    Inventors: Gerald J. Gleich, Russell Morris Condie, Debra Eckert, Kristin M. Leiferman, Kathryn A. Peterson, Hedieh Saffari
  • Publication number: 20230310662
    Abstract: Disclosed are compositions and methods for diagnosing eosinophilic esophagitis in a subject. Also disclosed are methods for monitoring the course of eosinophilic esophagitis in a subject before, during, and after treatment. In another aspect, disclosed is a method of diagnosing eosinophilic esophagitis or eosinophilic diseases in a subject, comprising detecting an eosinophil granule protein in the mucosal tissue of the esophagus or other organs in a subject.
    Type: Application
    Filed: May 24, 2023
    Publication date: October 5, 2023
    Inventors: Leonard F. Pease, Hedieh Saffari, Gerald J. Gleich, Kristin M. Leiferman, Kathryn A. Peterson, Russell Morris Condie
  • Patent number: 11684681
    Abstract: Disclosed are methods of detecting eosinophil degranulation in the respiratory tract of subjects. Also, disclosed are methods of producing medical images of the respiratory tract of subjects. The method can include administering radiolabeled heparin to the respiratory tract of subjects, wherein the radiolabeled heparin binds to one or more eosinophil granule protein in the mucosal tissue of the respiratory tract.
    Type: Grant
    Filed: July 19, 2021
    Date of Patent: June 27, 2023
    Assignee: UNIVERSITY OF UTAH RESEARCH FOUNDATION
    Inventors: Leonard F. Pease, Hedieh Saffari, Gerald J. Gleich, Kristin M. Leiferman, Kathryn A. Peterson, Russell Morris Condie
  • Publication number: 20220324937
    Abstract: The present disclosure relates to methods for expressing human insulin derivative in which the motif Leucine-Proline-X-Threonine appears at end of B-chain, where X is any amino acid residue. Said human insulin derivative is expressed using insulin derivative peptide and sortase. The method is to translate a nucleotide sequence encoding a single chain peptide into a precursor of human insulin derivative and combine the single chain peptide with sortase to convert a human insulin derivative precursor into a fully folded, biologically active human insulin derivative.
    Type: Application
    Filed: April 7, 2022
    Publication date: October 13, 2022
    Inventor: Arri Russell Morris
  • Publication number: 20220195005
    Abstract: The present invention relates to insulin derivatives which, in comparison to insulin glulisine and similar derivatives, has a simplified process for synthesis. In particular, the present invention relates to insulin derivatives or physiologically tolerable salts thereof in which the motif Leucine-Proline-X-Threonine appears at the end of the B-chain, where X is any amino acid residue. Due to the nature of the process, the A-chain and B-chain must begin with a Glycine amino acid residue.
    Type: Application
    Filed: February 22, 2022
    Publication date: June 23, 2022
    Inventor: Arri Russell Morris
  • Patent number: 11261228
    Abstract: The present invention relates to insulin derivatives which, in comparison to insulin glulisine and similar derivatives, has a simplified process for synthesis. In particular, the present invention relates to insulin derivatives or physiologically tolerable salts thereof in which the motif Leucine-Proline-X-Threonine appears at the end of the B-chain, where X is any amino acid residue. Due to the nature of the process, the A-chain and B-chain must begin with a Glycine amino acid residue.
    Type: Grant
    Filed: December 18, 2019
    Date of Patent: March 1, 2022
    Inventor: Arri Russell Morris
  • Publication number: 20220054662
    Abstract: Also disclosed are methods
    Type: Application
    Filed: July 19, 2021
    Publication date: February 24, 2022
    Inventors: Leonard F. Pease, Hedieh Saffari, Gerald J. Gleich, Kristin M. Leiferman, Kathryn A. Peterson, Russell Morris Condie
  • Patent number: 11065351
    Abstract: Disclosed are compositions and methods for diagnosing eosinophilic esophagitis in a subject. Also disclosed are methods for monitoring the course of eosinophilic esophagitis in a subject before, during, and after treatment. In another aspect, disclosed is a method of diagnosing eosinophilic esophagitis or eosinophilic diseases in a subject, comprising detecting an eosinophil granule protein in the mucosal tissue of the esophagus or other organs in a subject.
    Type: Grant
    Filed: July 3, 2019
    Date of Patent: July 20, 2021
    Assignee: University of Utah Research Foundation
    Inventors: Leonard F. Pease, Hedieh Saffari, Gerald J. Gleich, Kristin M. Leiferman, Kathryn A. Peterson, Russell Morris Condie
  • Publication number: 20210188938
    Abstract: The present invention relates to insulin derivatives which, in comparison to insulin glulisine and similar derivatives, has a simplified process for synthesis. In particular, the present invention relates to insulin derivatives or physiologically tolerable salts thereof in which the motif Leucine-Proline-X-Threonine appears at the end of the B-chain, where X is any amino acid residue. Due to the nature of the process, the A-chain and B-chain must begin with a Glycine amino acid residue.
    Type: Application
    Filed: December 18, 2019
    Publication date: June 24, 2021
    Inventor: Arri Russell Morris
  • Publication number: 20200196939
    Abstract: Described herein are various principles related to collecting and analyzing fertility data for female humans. The underlying concept is that a woman's hormones fluctuate throughout the menstrual cycle, affecting optimal exercise routines and general health practices. A dedicated sensor may be used to collect fertility data, or an estimate may be derived from the individual's menstrual history. Once collected or estimated, the fertility data is factored with other variables to determine the optimal exercise routine or general health habits for the woman. The recommendations are communicated to the woman, who may provide feedback to further improve future recommendations.
    Type: Application
    Filed: December 23, 2018
    Publication date: June 25, 2020
    Inventor: Arri Russell Morris
  • Publication number: 20200016282
    Abstract: Disclosed are compositions and methods for diagnosing eosinophilic esophagitis in a subject. Also disclosed are methods for monitoring the course of eosinophilic esophagitis in a subject before, during, and after treatment. In another aspect, disclosed is a method of diagnosing eosinophilic esophagitis or eosinophilic diseases in a subject, comprising detecting an eosinophil granule protein in the mucosal tissue of the esophagus or other organs in a subject.
    Type: Application
    Filed: July 3, 2019
    Publication date: January 16, 2020
    Inventors: Leonard F. Pease, Hedieh Saffari, Gerald J. Gleich, Kristin M. Leiferman, Kathryn A. Peterson, Russell Morris Condie
  • Patent number: 10376602
    Abstract: Disclosed are compositions and methods for diagnosing eosinophilic esophagitis in a subject. Also disclosed are methods for monitoring the course of eosinophilic esophagitis in a subject before, during, and after treatment. In another aspect, disclosed is a method of diagnosing eosinophilic esophagitis or eosinophilic diseases in a subject, comprising detecting an eosinophil granule protein in the mucosal tissue of the esophagitis or other organs in a subject.
    Type: Grant
    Filed: September 29, 2017
    Date of Patent: August 13, 2019
    Assignee: UNIVERSITY OF UTAH RESEARCH FOUNDATION
    Inventors: Leonard F. Pease, Hedieh Saffari, Gerald J. Gleich, Kristin M. Leiferman, Kathryn A. Peterson, Russell Morris Condie
  • Publication number: 20180036440
    Abstract: Disclosed are compositions and methods for diagnosing eosinophilic esophagitis in a subject. Also disclosed are methods for monitoring the course of eosinophilic esophagitis in a subject before, during, and after treatment. In another aspect, disclosed is a method of diagnosing eosinophilic esophagitis or eosinophilic diseases in a subject, comprising detecting an eosinophil granule protein in the mucosal tissue of the esophagitis or other organs in a subject.
    Type: Application
    Filed: September 29, 2017
    Publication date: February 8, 2018
    Inventors: Leonard F. Pease, Hedieh Saffari, Gerald J. Gleich, Kristin M. Leiferman, Kathryn A. Peterson, Russell Morris Condie
  • Patent number: 9789212
    Abstract: Disclosed are compositions and methods for diagnosing eosinophilic esophagitis in a subject. Also disclosed are methods for monitoring the course of eosinophilic esophagitis in a subject before, during, and after treatment.
    Type: Grant
    Filed: May 17, 2013
    Date of Patent: October 17, 2017
    Assignee: UNIVERSITY OF UTAH RESEARCH FOUNDATION
    Inventors: Leonard F. Pease, Hedieh Saffari, Gerald J. Gleich, Kristin M. Leiferman, Kathryn A. Peterson, Russell Morris Condie
  • Patent number: 9654233
    Abstract: A method includes determining a total forward power using a frequency domain version of a forward signal transmitted over a cable/connector system to one or more antennas. The method includes determining a total reflected power using a frequency domain version of a reflected signal including a reflected version of the forward signal. The method also includes determining a condition of the cable/connector system using the total forward power and the total reflected power. The method may include determining an estimated reflection coefficient based on the total forward power and the total reflected power and associating the estimated reflection coefficient with the condition of the cable/connector system. Apparatus, program products, and software are also disclosed.
    Type: Grant
    Filed: April 4, 2013
    Date of Patent: May 16, 2017
    Assignee: Nokia Solutions and Networks Oy
    Inventors: Darrell Barabash, Russell Morris
  • Patent number: 9385820
    Abstract: A method includes accessing sets of correlation values, each set corresponding to a correlation performed between a number of first samples and a same number of second samples. The sets of correlation values were determined by aligning the number of the first samples with selected second samples and sliding the number of first samples across the second samples to select different sets of the second samples. The first samples are samples of a forward signal transmitted over a cable/connector system to one or more antennas, and the second samples are samples of a reflected RF signal that comprises a reflected version of the forward signal. The method includes determining a maximum value from the plurality of sets of correlation values, and associating the maximum value with a return loss of the cable/connector system. Apparatus, computer programs, and program products are also disclosed.
    Type: Grant
    Filed: October 12, 2012
    Date of Patent: July 5, 2016
    Assignee: Nokia Solutions and Networks Oy
    Inventors: Darrell Barabash, Russell Morris
  • Publication number: 20160020860
    Abstract: A method includes determining a total forward power using a frequency domain version of a forward signal transmitted over a cable/connector system to one or more antennas. The method includes determining a total reflected power using a frequency domain version of a reflected signal including a reflected version of the forward signal. The method also includes determining a condition of the cable/connector system using the total forward power and the total reflected power. The method may include determining an estimated reflection coefficient based on the total forward power and the total reflected power and associating the estimated reflection coefficient with the condition of the cable/connector system. Apparatus, program products, and software are also disclosed.
    Type: Application
    Filed: April 4, 2013
    Publication date: January 21, 2016
    Inventors: Darrell BARABASH, Russell MORRIS
  • Publication number: 20150288461
    Abstract: A method includes accessing sets of correlation values, each set corresponding to a correlation performed between a number of first samples and a same number of second samples. The sets of correlation values were determined by aligning the number of the first samples with selected second samples and sliding the number of first samples across the second samples to select different sets of the second samples. The first samples are samples of a forward signal transmitted over a cable/connector system to one or more antennas, and the second samples are samples of a reflected RF signal that comprises a reflected version of the forward signal. The method includes determining a maximum value from the plurality of sets of correlation values, and associating the maximum value with a return loss of the cable/connector system. Apparatus, computer programs, and program products are also disclosed.
    Type: Application
    Filed: October 12, 2012
    Publication date: October 8, 2015
    Inventors: Darrell Barabash, Russell Morris
  • Publication number: 20150132227
    Abstract: Disclosed are compositions and methods for related to echogenic contrast agents. Also disclosed are methods and compositions for diagnosing eosinophilic esophagitis in a subject. Also disclosed are methods for producing a medical image of a tissue. Also disclosed are methods of monitoring the progression of eosinophilic esophagitis in a subject before, during, and after treatment.
    Type: Application
    Filed: April 18, 2013
    Publication date: May 14, 2015
    Inventors: Leonard F. Pease, Hedieh Saffari, Kathryn Peterson, Kristin Leiferman, Anne Kennedy, Russell Morris Condie, Gerald Gleich
  • Publication number: 20150132221
    Abstract: Disclosed are compositions and methods for diagnosing eosinophilic esophagitis in a subject. Also disclosed are methods for monitoring the course of eosinophilic esophagitis in a subject before, during, and after treatment.
    Type: Application
    Filed: May 17, 2013
    Publication date: May 14, 2015
    Inventors: Leonard F. Pease, Hedieh Saffari, Gerald J. Gleich, Kristin M. Leiferman, Kathryn A. Peterson, Russell Morris Condie